Recommendations Russian Society of Dermatovenerologists and Cosmetologists for systemic treatment of psoriasis during the pandemic COVID-19

Cover Page

Cite item

Full Text

Abstract

Below you will find the analysis of the first published data and international clinical recommendations for the systemic treatment of patients with moderate and severe psoriasis in the context of the COVID-19 pandemic in different countries (France, Italy, USA, Spain, and Germany).

About the authors

Alexey A. Kubanov

All-Russian Public Organization “Russian Society of Dermatovenerologists and Cosmetologists”

Author for correspondence.
Email: alex@cnikvi.ru

Dr. Sci. (Med.), Prof., Corresponding Member of the Russian Academy of Sciences, Director

Russian Federation, Moscow

Andrey L. Bakulev

All-Russian Public Organization “Russian Society of Dermatovenerologists and Cosmetologists”

Email: info@sarderma.ru
ORCID iD: 0000-0002-1450-4942

Dr. Sci. (Med.), Prof., Head of the Department of Dermatology and Cosmetology

Russian Federation, Moscow

Muza M. Kokhan

All-Russian Public Organization “Russian Society of Dermatovenerologists and Cosmetologists”

Email: alex@cnikvi.ru

Dr. Sci. (Med.), Prof., Head of the Scientific Clinical Department of Dermatology

Russian Federation, Moscow

Olga Yu. Olisova

All-Russian Public Organization “Russian Society of Dermatovenerologists and Cosmetologists”

Email: alex@cnikvi.ru

Dr. Sci. (Med.), Prof., Head of the V.A. Rakhmanov Department of Skin and Venereal Diseases

Russian Federation, Moscow

ALexey V. Samtsov

All-Russian Public Organization “Russian Society of Dermatovenerologists and Cosmetologists”

Email: alex@cnikvi.ru

Dr. Sci. (Med.), Prof., Head of the Department of Skin and Venereal Diseases

Russian Federation, Moscow

Evgeny V. Sokolovskiy

All-Russian Public Organization “Russian Society of Dermatovenerologists and Cosmetologists”

Email: alex@cnikvi.ru

Dr. Sci. (Med.), Prof., Head of the Department of Dermatology and Venereology with a Hospital

Russian Federation, Moscow

Vladislav R. Khairutdinov

All-Russian Public Organization “Russian Society of Dermatovenerologists and Cosmetologists”

Email: alex@cnikvi.ru

Dr. Sci. (Med.)., Assoc. Prof., Assoc. Prof. of the Department of Skin and Sexually Transmitted Diseases

Russian Federation, Moscow

Marianna M. Khobeish

All-Russian Public Organization “Russian Society of Dermatovenerologists and Cosmetologists”

Email: alex@cnikvi.ru

Cand. Sci. (Med.), Assoc. Prof. Department of Dermatology and Venereology with a Hospital

Russian Federation, Moscow

References

  1. European Commission. Novel coronavirus 2019-nCoV. URL: https://ec.europa.eu/health/coronavirus_en.
  2. FDA. Novel coronavirus (2019-nCoV) URL: https://www.fda.gov/emergency-preparedness-and response/mcm-issues/novel-coronavirus-2019-ncov
  3. Кубанова А. А., Кубанов А. А., Знаменская Л. Ф., Чикин В. В., Бакулев А. Л., Хобейш М. М. и др. Псориаз. В кн.: Федеральные клинические рекомендации. Дерматовенерология, 2015: Болезни кожи. Инфекции, передаваемые половым путем. 5-е изд., перераб. и доп. М.: Деловой экспресс, 2016: 415—470. [Kubanova A.A., Kubanov A.A., Znamenskaya L.F., Chikin V.V., Bakulev A.L., Khobeish M.M., etc. Psoriasis. In: Federal clinical guidelines. Dermatovenereology, 2015: Skin diseases. Sexually transmitted infections. 5th ed., reprint. and add. M.: Business Express, 2016: 415—470 (Russia).]
  4. Shah P., Zampella J. G. Use of Systemic Immunomodulatory Therapies During the Coronavirus Disease 2019 (COVID-19) Pandemic. 2020 Apr 9. Journal of the American Academy of Dermatology. doi: 10.1016/j.jaad.2020.03.056
  5. Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395 (10223): 497—506.
  6. Ma W-T., Yao X-T., Peng Q., Chen D-K. The protective and pathogenic roles of IL-17 in viral infections: friend or foe? Open Biology. 2019; 9 (7): 190109.
  7. Li C., Yang P., Sun Y. et al. IL-17 response mediates acute lung injury induced by the 2009 pandemic influenza A (H1N1) virus. Cell Res. 2012; 22 (3): 528—538.
  8. Price KN et al. COVID-19 and Immunomodulator/Immunosuppressant Use in Dermatology. J Am Acad Dermatol. 2020 Mar 26. pii: S0190-9622(20)30466-7. doi: 10.1016/j.jaad.2020.03.046.
  9. https://evenements-sfd.fr/coronavirus-covid-19/
  10. https://www.sidemast.org/blog/coronavirus
  11. Hruza G. J., Grant-Kels J. M., Van Beek M/J/ at al/ Guidance on the use of biologic agents during COVID-19 outbreak. AAD. 2020.
  12. https://aedv.es/?s=covid
  13. https://aedv.es/coronavirus-los-pacientes-dermatologicos-no-deben-suspender-sus-tratamiento/
  14. Augustin M., von Kiedrowsky R., Korber A. et al. Recommendations for systemic therapy in persons with psoriasis during the pandemic phase of SARS-COV-2 (corona virus). PsoNet, 2020.
  15. Wang T., Du Z., Zhu F. et al. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet. 2020.
  16. Yang J., Zheng Y., Gou X. et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020.
  17. Fang L., Karakiulakis G. Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2020 Kubanov A.A., Bakulev A.L., Kokhan M.M., Olisova O.Y., Samtsov A.V., Sokolovskiy E.V., Khairutdinov V.R., Khobeish M.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).